Goodbody Health Stock Price To Sales
Goodbody Health fundamentals help investors to digest information that contributes to Goodbody Health's financial success or failures. It also enables traders to predict the movement of Goodbody OTC Stock. The fundamental analysis module provides a way to measure Goodbody Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Goodbody Health otc stock.
Goodbody |
Goodbody Health OTC Stock Price To Sales Analysis
Goodbody Health's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Goodbody Health Price To Sales | 0.15 X |
Most of Goodbody Health's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Goodbody Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Goodbody Health has a Price To Sales of 0.1452 times. This is 99.32% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to sales for all United States stocks is 98.73% higher than that of the company.
Goodbody Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Goodbody Health's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Goodbody Health could also be used in its relative valuation, which is a method of valuing Goodbody Health by comparing valuation metrics of similar companies.Goodbody Health is currently under evaluation in price to sales category among its peers.
Goodbody Fundamentals
| Return On Equity | -0.56 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.23) % | |||
| Operating Margin | (0.11) % | |||
| Current Valuation | (884.3 K) | |||
| Shares Outstanding | 36.5 M | |||
| Shares Owned By Insiders | 2.09 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Book | 0.16 X | |||
| Price To Sales | 0.15 X | |||
| Revenue | 17.06 M | |||
| Gross Profit | 1.12 M | |||
| EBITDA | (13.74 K) | |||
| Net Income | (2.31 M) | |||
| Cash And Equivalents | 3.74 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 249.82 K | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 2.52 X | |||
| Book Value Per Share | 0.15 X | |||
| Cash Flow From Operations | 1.86 M | |||
| Earnings Per Share | (0.01) X | |||
| Target Price | 0.35 | |||
| Beta | -1.24 | |||
| Market Capitalization | 2.64 M | |||
| Total Asset | 10.84 M | |||
| Z Score | 7.0 | |||
| Net Asset | 10.84 M |
About Goodbody Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Goodbody Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Goodbody Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Goodbody Health based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Goodbody OTC Stock
Goodbody Health financial ratios help investors to determine whether Goodbody OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Goodbody with respect to the benefits of owning Goodbody Health security.